Newsletter Archive

41. 05.01.19 -- What's In A Name? FDA Proposes Updates To Biosimilar Naming Policy
    5/1/2019
    05/01/19 BioProcess Online Newsletter
42. 04.29.19 -- Controlling Bioburden: Cleaning, Sanitizing, Sterilizing, Or Wishing It Away?
    4/29/2019
    04/29/19 BioProcess Online Newsletter
43. 04.24.19 -- The Unique Demands Of Cell And Gene Therapy Supply Chains
    4/24/2019
    04/24/19 BioProcess Online Newsletter
44. 04.23.19 -- Addressing The Challenges Of Next-Generation Biotherapeutics
    4/23/2019
    04/23/19 BioProcess Online Newsletter
45. 04.22.19 -- Beyond Human Error: Blunt- Or Sharp-End Decisions Impact Life Sciences
    4/22/2019
    04/22/19 BioProcess Online Newsletter
46. 04.17.19 -- 4 Strategies For Success In The CAR-T 2.0 Marketplace
    4/17/2019
    04/17/19 BioProcess Online Newsletter
47. 04.16.19 -- Reducing Complexity In Drug Development And Formulation
    4/16/2019
    04/16/19 BioProcess Online Newsletter
48. 04.15.19 -- Cryogenic Transport For Gene Therapy Products -- The Pros And Cons
    4/15/2019
    04/15/19 BioProcess Online Newsletter
49. 04.12.19 -- Trends In Bioprocess Development - Top Discussions From Bioprocessing Asia
    4/12/2019
    04/12/19 BioProcess Online Newsletter
50. 04.11.19 -- Are You Ready For The Changing Biopharma Pipeline?
    4/11/2019
    04/11/19 BioProcess Online Newsletter